Introduction: hypertensive diseases in pregnancy are the leading medical problem during pregnancy. Some of the women affected remain
Introduction
Hypertension is defined by the World Health Organization (WHO) as a systolic blood pressure more or equal to 140 mmHg and/or a diastolic blood pressure more or equal to 90 mmHg [1] . It complicates about 10% of all pregnancies and represent the first medical problem according to the American College of Obstetricians and Gynecologists.
Hypertensive diseases in pregnancy are divided in 4 categories: chronic hypertension, gestational hypertension, preeclampsia (PE) and chronic hypertension with superimposed PE [2] . Chronic hypertension is defined as hypertension that is diagnosed before pregnancy or before 20 weeks of gestation. Hypertension that is first diagnosed after 20 weeks' gestation and persists for greater than 12 weeks postpartum is also considered chronic hypertension.
Gestational hypertension is defined as hypertension that develops in pregnancy after 20 weeks' gestation and resolves before 12 weeks postpartum in the absence of proteinuria (<300mg of protein in 24 h). PE is a syndrome and is typically characterized as new-onset hypertension and proteinuria (>300mg of protein in 24 h) diagnosed in pregnancy often after 20 weeks' gestation [3] . However, according to the latest definitions, other findings such as new-onset thrombocytopenia, renal impairment, neurological complications, liver involvement and fetal growth restriction may substitute to new-onset proteinuria. PE can be classified either as early-onset (before 34 weeks' gestation) or late-onset (at or after 34 weeks' gestation) [4] .
Hypertensive diseases in pregnancy are one of the three leading causes of maternal death in the world together with hemorrhage and sepsis/infection. They cause approximately 14% of all maternal deaths worldwide and are more frequent in low and middle income countries where their incidence keeps rising [5] . Thus, in Cameroon Tebeu et al found 17.5% of maternal deaths related to hypertensive diseases in pregnancy in 2007 while Foumane et al found 22.4% in 2010 [6, 7] . These hypertensive diseases in pregnancy, especially PE, make the women affected to be more vulnerable to future cardiovascular disease. After a PE, there may be metabolic alterations causing endothelial dysfunction, sympathetic hyperactivity, peripheral vascular and renovascular resistance, insulin resistance, hyperlipidemia and obesity. All these can in turn lead to often silent diseases such as diabetes, kidney injury and hypertension [8] . The latter is the main risk factor of stroke and coronary artery disease, which are currently the leading causes of death in the World [9] . Many studies showed that women who had PE are at least twice as likely to have ischemic heart disease and stroke compared to those who had normotensive pregnancies and this risks seem to be mediated by a greater risk of future chronic hypertension after PE [4, [10] [11] [12] . It therefore appeared necessary to us to identify the factors associated to the occurrence of chronic hypertension after PE on which we may act in order to reduce this future cardiovascular risk in our context where two thirds of cardiovascular disease mortality is registered.
Methods
Type of study: we carried out a retrospective cohort study over an Study population: all women who had PE during the study period were included in the study. The minimal follow-up period after pregnancy was 12 months. We excluded all women who had superimposed PE from the study. 
Results
Our cohort included 140 women who had preeclampsia. Four of them were excluded from the study because they had superimposed preeclampsia. The mean follow-up period was 3.7 years. Thirty two women had persistent hypertension at the end of our study, which gave us a prevalence of 23.53% and an incidence rate of 2.85% per year. Table 1 show the baseline characteristics of our study population. We can see that the mean age, weight, BMI and gravidity were significantly greater for women who remains hypertensive. On the other hand, the onset of PE was significantly earlier in these last. Figure 1 shows blood pressures evolution after delivery. We see that of the thirty two women who remained hypertensive, five had persistent hypertension since delivery while the other first of all had a normalization of their blood pressure which later on raised up. After adjustment for confounders using multiple logistic regression (Table   2 ), the factors found to be associated to persistent hypertension 
Discussion
The aim of our study was to determine the prevalence, incidence and factors associated to the progression of PE to chronic hypertension. the Generation R study that low maternal socioeconomic status is a strong risk factor for PE and that only a small part of this association can be explained by the mediating effects of established risk factors for PE [15] . So, higher risk of PE also leads to higher risk of chronic hypertension after pregnancy.
We found an association between the number of pregnancies (>4) and the risk of chronic hypertension. This can be explained by the fact that women who had a preeclamptic pregnancy are at higher risk of having PE in subsequent pregnancies. In addition in our study, women who had more than 4 pregnancies were more housewives (p<0.05). Low socioeconomic study may therefore be a mediating factor in this association. Women who had early onset PE had a 9 fold firstly by the fact that obesity is an independent risk factor of PE and secondly by the fact that obesity is also associated to the risk of chronic hypertension. This results highlights the necessity to create strategies to specifically follow-up and take care of women who had PE and who have these risk factors of progression to chronic hypertension.
Conclusion
The occurrence of chronic hypertension following PE is common in 
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